ISRCTN72553848已完成2 期
Double-blind, placebo-controlled, randomised phase 2 trial of IH636 grape seed proanthocyanidin (GSPE) in patients with adverse effects of high dose breast radiotherapy
The Royal Marsden NHS Foundation Trust (UK)0 个研究点目标入组 0 人开始时间: 2002年10月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Past history of early breast cancer (T1-3 N0-1 M0)
- •2. Past history of radiotherapy to the breast
- •3. A minimum of 24 months post radiotherapy
- •4. No evidence of cancer recurrence
- •5. Palpable breast induration due to previous radiotherapy
- •6. Ability to attend The Royal Marsden Hospital, Sutton for assessments
- •7. Written informed consent
排除标准
- •Not provided at time of registration
研究者
相似试验
进行中（未招募）
不适用
Double-blind, placebo-controlled, randomized phase II-study investigating the efficacy of Bevacizumab for symptom control in patients with malignant ascites due to advanced-stage gastrointestinal cancerspatients with malignant ascites due to advanced-stage gastro-intestinal cancersMedDRA version: 14.1Level: PTClassification code 10017758Term: Gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10015362Term: Esophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10049010Term: Carcinoma hepatocellularSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10025538Term: Malignant ascitesSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10033604Term: Pancreatic cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2009-014725-16-DEAIO Studien gGmbH
已完成
3 期
Efficacy and safety of Octanorm in patients with dermatomyositisMusculoskeletal DiseasesDermatomyositisISRCTN11520709Octapharma Pharmazeutika Produktionsges.m.b.H.78
已完成
1 期
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique.Cholera diseaseCholera/ prevention & controlHealthy VolunteersVibrio InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsWaterborne DiseasesEnvironmental IllnessRPCEC00000051Finlay Institute120
进行中（未招募）
不适用
Randomized, double-blind, placebo controlled phase II study comparing the safety of MDX-010 BMS-734016 administered with or without prophylactic oral budesonide Entocort EC in patients with unresectable stage III or IV malignant melanoma. - NDMedDRA version: 6.1Level: HLTClassification code 10027156MelanomaEUCTR2005-002678-31-ITBRISTOL-M.SQUIBB100
尚未招募
2 期
Randomised, double-blind, placebo controlled phase II study of the efficacy of Phospha-E biomarkers of inflammation, in patients with metabolic syndrome and mild to moderate hyperlipidemia.Metabolic and Endocrine - Other metabolic and endocrine disordersMetabolic SyndromeACTRN12607000343404Phosphagenics Limited160